About the Glucocorticoids Impact Working Group

Glucocorticoids (GC), more commonly known as steroids, are used to treat many inflammatory diseases. The GC Impact Group studies the good and bad effects of GCs. Side effects, or adverse effects, of GCs are common. Some are easily measured and can usually be controlled such as high blood pressure and high blood sugar levels. Some are harder to control such as weight gain, osteoporosis (bone thinning) and cataracts. Effects such as mood and sleep disturbance, easy bruising and body shape changes are harder to measure. Certain effects are ‘events’, which are less common such as infections and fractures, whilst others are common ‘experiences’ that have variable effects such as weight gain, skin changes and sleep disturbance.

Another difficulty is knowing whether it is the GC, another medication used at the same time or the disease being treated leading to these effects is often difficult to work out. It is also not known which effects are most important and concerning to patients.

susan goodman

Susan Goodman

Co-Chair

catherine hill

Catherine Hill

Co-Chair

sarah mackie

Sarah Mackie

Co-Chair

jonathan cheah

Jonathan Cheah

Fellow

joanna tieu

Joanna Tieu

Fellow

susan beard

Susan Beard

Patient Research Partner

Pam Richards

Pam Richards

Patient Research Partner

Glucocorticoid Impact Whiteboard Overview

Glucocorticoid Impact Plenary Video

OMERACT Endorsed Core Domain Set for Glucocorticoid Impact

GC cds

Working Group Members:

Rachel Black
Maarten Boers
Peter Brooks
Robin Christensen
Susan Goodman
Eileen Harrison
Catherine Hill

Elizabeth Hoon
Lana Lai
Anne Lyddiatt
Amye Leong
Sarah Mackie
Michael Nebesky
Lorna Neill

Linda Nelsen
Pam Richards
Joanna Robson
Ken Saag
Marieke Scholte-Voshaar
Lee Simon
Peter Tugwell

Scroll to Top